OncoLize raises US$ 1.7 million to treat pancreatic cancer locally ‘From the Inside’

Leiden-based Dutch start-up OncoLize has closed a US$ 1.7 million first round to extend their preclinical success with a localized drug delivery system to treat Pancreatic- and Lung cancer.

OncoLize technology patent granted in the USA

The USPTO has granted the patent application valid by RCSI covering the OncoLize technology.

OncoLize Joins immuno-modulating consortium backed by the Dutch Cancer Foundation

OncoLize has joined forces with a small but highly specialized consortium around the department of Engineered Therapeutics led byprof. dr. Jai Prakash from the University of Twente in the Netherlands.

OncoLize expert column in Dutch news paper ‘Financieel Dagblad’ 10th december 2020

Mike de Leeuw was invited to write an expert column in a special feature of ‘Het Financieel Dagblad’ covering a.o. oncology development in the Netherlands. You can read the column here.

OncoLize joins Dutch Trade Mission April 8-17

OncoLize will join the Dutch trade mission to China, hosted by our Prime Minister Mark Rutte and several cabinet members. OncoLize features prominent in the Life Sciences and Health group, visiting Beijing (9-10)...

Neuro-Oncology symposium Maastricht 11th January 2018

OncoLize participated in the neuro-oncology symposium held in Maastricht, NL on the evening of the 11th January 2018. Links were explained between the grade of Glioma’s, eplileptic seizures and molecular biomarkers that predict low grade...

OncoLize wins Best Biotech Pitch award at the 11th European Venture Contest Finals 2017

“The award winning pitch by Oncolize clearly explained the unmet needs, the solution and the potential for patients, doctors and investors”. On the 11th & 12th of December 2017 the 11th European Venture Contest Finals...